We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Can Intra-tumor Immunotherapy Reduce Side Effects?

News   Oct 24, 2018 | Original story from Houston Methodist

 
Implantable Drug-eluting Nanofluidic Device Delivers Immunotherapy

Smaller than a grain of rice, this tiny device, invented by a Houston Methodist nanoscientist, delivers immunotherapy straight into a tumor, eliminating both side effects and the need for multiple IV treatments. Credit: Houston Methodist

 
 
Advertisement
 

RELATED ARTICLES

Pilot Study Suggests That Ivermectin Can Help To Treat Mild COVID-19

News

Results from a small pilot study indicate that the early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19.

READ MORE

Understanding How Cancer Cells Adapt To Survive Harsh Tumor Microenvironments

News

A new study investigates the conditions that select for a metabolic adaptation known as the Warburg Effect, whereby malignant cells choose to ferment glucose to lactic acid as a means to produce energy.

READ MORE

Single-Cell Test Uncovers How Drugs Kill Cancer Cells

News

Researchers have developed a novel method to see, at a single-cell/organelle level, how drugs induce cancer cell death.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE